{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-002171","form_type":"8-K","ticker":"MODD","cik":"0001074871","company_name":"Modular Medical, Inc.","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.134817+00:00","generated_at":"2026-06-10T03:46:28.688870+00:00","sec_items":["3.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Modular Medical adopts FDA milestone bonus program; execs get options tied to MODD-1 clearance","bullets":["CEO Besser receives 135,136 options for 510(k) submission by Jan 31, 2024; no options for clearance milestone.","Chairman/CFO DiPerna gets 90,091 submission options + 45,046 clearance options; COO Schmid gets 37,538 + 18,769.","Options priced at $1.11/share, 10-year term; cancellable if milestones missed.","Non-executive employee aggregate bonus pool ~$757,000 in cash or options at employee election.","Milestone 2 requires FDA clearance of MODD-1 insulin pump by August 1, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-002171","json":"https://secwatch.observer/filing/0001013762-23-002171.json","markdown":"https://secwatch.observer/filing/0001013762-23-002171.md","text":"https://secwatch.observer/filing/0001013762-23-002171.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1074871/000101376223002171/0001013762-23-002171-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1074871/000101376223002171/ea186338-8k_modular.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:46:28.688870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}